Back

Discussant review - The effect of randomization to aspirin in ASCEND.

26 August 2018 (16:57 - 17:02)
Organised by:
Congress Presentation Part of: Hot Line Session 2 Diabetes and the Heart ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Sigrun Halvorsen

Oslo University Hospital Ulleval, Oslo (Norway)

12 More presentations in this session

Presentation thumbnail
Opening question - ASCEND.
Slides Video
Presentation thumbnail
ASCEND - A randomized trial of aspirin versus placebo for primary cardiovascular prevention in 15,480 people with diabetes
Professor J. Armitage (Oxford, GB)
Slides Video
Presentation thumbnail
Questions from the audience and discussion.
Presentation thumbnail
Concluding question - ASCEND.
Slides Video
Presentation thumbnail
ASCEND - A randomized trial of omega-3 fatty acids (fish oil) versus placebo for primary cardiovascular prevention in 15,480 people with diabetes
Professor L. Bowman (Oxford, GB)
Slides Video

Access the full session

Session thumbnail
Hot Line Session 2

The Event

Event poster

ESC Congress 2018

26 August 2018 16:57 CET
You may be interested in
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
6 July 2023
thumbnail
Congress Presentation
Is pre-diabetes a predictor of events in patients with atrial fibrillation?
25 August 2023
thumbnail
Congress Presentation
Pharmacodynamic effects of vorapaxar as an add-on antiplatelet therapy in patients with and without diabetes mellitus: the optimizing anti-platelet therapy in diabetes mellitus (OPTIMUS)-5 study
1 September 2019
thumbnail
Webinar
Diabetes and ACS - enhancing post-discharge outcomes after primary PCI
26 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources